A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Exclusion Criteria

• •Re-transplantation due to viral recurrence
• •Positive HIV or HCV test at time of transplantation
• •HBV-DNA positive at OLT
• •Patients having received organs from HBsAg positive donors
• •Pregnancy or unreliable contraceptive measures or lactation period (females only)
• •Known intolerance to immunoglobulins or comparable substances (e.g. vaccination reaction)
• •Known intolerance to proteins of human origin
• •Participation in another interventional clinical trial within 90 days before entering the study or during the study and/or previous participation in this study (except screening failures)
• •Suspicion of drug and/or alcohol abuse
• •Inability or lacking motivation to participate in the study
• •Employee or direct relative of an employee of the CRO, the study site, or Biotest